Caring for the Ages
May 4, 2026
Showing 21 - 30 of 2443 results
Caring for the Ages
May 4, 2026
Tramadol Reconsidered: Limited Benefit, Real Risk, and a Narrowing Role in Older Adults
Caring for the Ages
April 6, 2026
Getting Functional Medicine on the PALTC Radar
Even as people age, lifestyle and other changes can still positively impact outcomes, well-being, and longevity. So, it’s not surprising that functional medicine, which involves a holistic, person-centered approach to health care that focuses on root causes of illness instead of just treating symptoms, is ...
Caring for the Ages
April 6, 2026
Celebrating 30 Years of Impact—Advancing PALTC Together
As the Foundation for Post-Acute and Long-Term Care Medicine begins its 30th year, we are reflecting on the remarkable impact made possible by the generosity and commitment of our national community.
Caring for the Ages
April 6, 2026
President’s Message: Responsive, Resilient, and Ready: Launching a Year of Impact and Connection
It was wonderful to connect with many of you at last month’s PALTC26 Annual Conference. Our post-acute and long-term care community is truly special, and I look forward to this event every year. This year’s conference was especially meaningful for me, and I am honored to begin my term as president of PALTm...
Caring for the Ages
April 6, 2026
April JAMDA Highlight
One of our highlighted articles for the current issue of JAMDA is the brief report by Dr. Deardorff and team, Can I Stay, or Must I Go Now? A Cohort Study of Discharge Appeals in a Post-Acute Skilled Nursing Facility.
Caring for the Ages
April 6, 2026
OIG Launches Nursing Home Opioid Investigation: What Medical Directors Need to Know Now
The Office of Inspector General (OIG) for the U.S. Department of Health and Human Services has announced a new investigation examining possible opioid overuse, misuse, or diversion in nursing homes. While federal scrutiny of psychotropics in long-term care is familiar terrain, this initiative signals renew...
Caring for the Ages
April 6, 2026
Suzetrigine: A First-in-Class Non-Opioid Analgesic — Promise With Vigilance
Suzetrigine (brand name Journavx) is a recently approved, first-in-class, oral, non-opioid analgesic indicated for the treatment of moderate to severe acute pain in adults. Approved by the U.S. Food and Drug Administration (FDA) in 2025, it represents the first novel mechanistic class of oral analgesic in ...
Caring for the Ages
April 6, 2026
Dehydration by Degrees: The Case for Targeted IV Hydration in Long-Term Care
Chronic subclinical hypohydration in SNF residents is real, measurable, and consequential — and the clinical and regulatory framework for addressing it already exists. This article is a response to Nursing Home Parenteral Therapies: Clinical Guidance and Payment Considerations in last month’s Caring for th...
Caring for the Ages
April 6, 2026
Smoking Cessation! What Can I Do?
Endless research has been done to evaluate the factors that initiate and lead to smoking addiction. The teenage years are usually the starting point for most smokers. It begins as a cool thing when company and peer pressure persuade them to perform certain acts. Rationalization and introspection are not th...
